JPRN-UMIN000019719
Completed
未知
Estimating the Effects of Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreatic Head using Inverse Probability of Treatment Weighting: A Dual-institution Observational Study - NACRT for PDAC
Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine0 sites504 target enrollmentNovember 9, 2015
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine
- Enrollment
- 504
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) Unresectable pancreatic cancer (NCCN criteria) (2\)Tumors with encasement or stenosis of the arteries, those abutted with the celiac axis (3\) Hematologic, renal, hepatic and respiratory dysfunction (4\)Active infections (5\) Severe cardiac disorder, renal disorder, liver disorder, ulcer with bleeding, intestinal tract paralysis, uncontrollable diabetes mellitus (6\) Presence of pleural effusion or ascites requiring drainage (7\)Pregnant females or nursing mothers who can not stop lactation. Patients or partners, who don't attempt to doing contraception during the study period. (8\) Severe mental disorder (9\) Severe drug hypersensitivity (10\) As determined by the principal investigator or the sub\-investigator the subject is not adequate to participate in the trial.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Prospective cohort study of neoadjuvant chemoradiotherapy using GEM and nabPTX for borderline resectable pancreatic cancerBorderline resectable pancreatic cancerJPRN-UMIN000018366Department of gastroenterological surgery, Yokohama city university graduate school of medicine100
Recruiting
Phase 2
Effect of chemoradiotherapy on locally advanced cancer of CardiaIRCT20140203016473N12Tabriz University of Medical Sciences60
Completed
Not Applicable
Prospective study of neoadjuvant chemotherapy for HER2 positive breast cancer.JPRN-UMIN000046338Sapporo Medical University24
Recruiting
Not Applicable
Prospective study of neoadjuvant chemotherapy with FEC100x4 for BRCAness cases in triple negative breast cancerBreast cancerJPRN-UMIN000029433Tokyo medical university70
Not yet recruiting
Not Applicable
Prediction of response to Neoadjuvant chemotherapy(bi-weeklyS1/Docetaxel therapy) in advanced gastric cancerGastric cancerJPRN-UMIN000011521Yokohama City University School of Medicine Department of Gastroenterological Surgery50